GB Global EV/EBIT
Cos'è EV/EBIT di GB Global?
EV/EBIT di GB Global Limited è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Consumer Discretionary settore su NSE rispetto a GB Global
Cosa fa GB Global?
GB Global Limited manufactures and sells textiles and garments in India. The company is involved in the yarn dyeing, weaving, printing, and processing activities. It also exports its products. The company was formerly known as Mandhana Industries Limited and changed its name to GB Global Limited in August 2019. GB Global Limited was incorporated in 1984 and is based in Mumbai, India.
Aziende con ev/ebit simili a GB Global
- Appili Therapeutics Inc ha EV/EBIT di N/A
- Chimeric Therapeutics Ltd ha EV/EBIT di N/A
- Quantum Cobalt ha EV/EBIT di N/A
- Lumos Diagnostics ha EV/EBIT di N/A
- Mednow ha EV/EBIT di N/A
- Hempfusion Wellness ha EV/EBIT di N/A
- GB Global ha EV/EBIT di N/A
- Intec Parent Inc ha EV/EBIT di N/A
- Tombill Mines ha EV/EBIT di N/A
- DiaMedica Therapeutics ha EV/EBIT di N/A
- Velodyne Lidar ha EV/EBIT di N/A
- Qualigen Therapeutics ha EV/EBIT di N/A
- NEXE Innovations ha EV/EBIT di N/A